1. Home
  2. Author
  3. Kipnes MS

Kipnes MS

References (2)

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy - Pratley_2009_Diabetes.Obes.Metab_11_167
Author(s) : Pratley RE , Kipnes MS , Fleck PR , Wilson C , Mekki Q
Ref : Diabetes Obes Metab , 11 :167 , 2009
Abstract : Pratley_2009_Diabetes.Obes.Metab_11_167
ESTHER : Pratley_2009_Diabetes.Obes.Metab_11_167
PubMedSearch : Pratley_2009_Diabetes.Obes.Metab_11_167
PubMedID: 19125778

Title : Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes - Herman_2006_J.Clin.Endocrinol.Metab_91_4612
Author(s) : Herman GA , Bergman A , Stevens C , Kotey P , Yi B , Zhao P , Dietrich B , Golor G , Schrodter A , Keymeulen B , Lasseter KC , Kipnes MS , Snyder K , Hilliard D , Tanen M , Cilissen C , De Smet M , De Lepeleire I , Van Dyck K , Wang AQ , Zeng W , Davies MJ , Tanaka W , Holst JJ , Deacon CF , Gottesdiener KM , Wagner JA
Ref : J Clinical Endocrinology Metab , 91 :4612 , 2006
Abstract : Herman_2006_J.Clin.Endocrinol.Metab_91_4612
ESTHER : Herman_2006_J.Clin.Endocrinol.Metab_91_4612
PubMedSearch : Herman_2006_J.Clin.Endocrinol.Metab_91_4612
PubMedID: 16912128